Learn more about whether BioCryst Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

President Donald Trump on Monday will sign a sweeping executive order that calls on the nation's health department to ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Donald Trump has signed an executive order, described as a “game changer”, which could hit Australia harder than any of his other moves since taking office.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and Neulasta. Humira now faces competition from seven biosimilars, while Neulasta has ...

The banning of pharmaceutical advertisements is not an assault on free speech. Big Pharma cannot be trusted with the health of Americans.

The foundations of psychedelic capitalism were largely created by public innovation at the public’s expense and are now in ...

A massive industrial development in Montreal‘s East End is aiming to make its mark by becoming North America’s largest ... their first major tenant, pharmaceutical distributor McKesson Canada ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take ...

AI usage is rapidly growing in the field of cancer. A study by Mordor Intelligence projects that the size of the AI in the cancer industry will be approximately $1.98 billion in 2025 and will grow to ...